Funds and ETFs Chugai Pharmaceutical Co., Ltd

4519

JP3519400000

Name	Weight	AuM	1st Jan change	Investor Rating
CSIF (IE) MSCI WORLD ESG LEADERS BLUE UCITS ETF - BH - EUR	0.08%	261 M€	-.--%	-
CSIF (IE) MSCI WORLD ESG LEADERS BLUE UCITS ETF - BH - CHF	0.08%	200 M€	+11.72%	-
CSIF (IE) MSCI WORLD ESG LEADERS BLUE UCITS ETF - B - USD	0.08%	488 M€	+14.46%
IMGP RBA RESPONSIBLE GLOBAL ALLOCATION ETF - USD	0.07%	7 M€	+0.11%	-
AMUNDI MSCI WORLD ESG LEADERS SELECT - UCITS ETF DR (C) - USD	0.07%	276 M€	+11.40%	-
LYXOR NET ZERO 2050 S&P WORLD CLIMATE PAB (DR) UCITS ETF - ACC - USD	0.06%	205 M€	-.--%
AMUNDI MSCI WORLD CLIMATE PARIS ALIGNED PAB UCITS ETF DR (C) - USD	0.05%	284 M€	-.--%
DAY HAGAN/NED DAVIS RESEARCH SMART SECTOR INTERNATIONAL ETF - USD	0.05%	35 M€	+5.55%	-
LEVERAGE SHARES 3X LONG TOTAL WORLD ETP SECURITIES - USD	0.05%	0 M€	0.00%	-
AMUNDI MSCI WORLD CLIMATE TRANSITION CTB UCITS ETF DR (C) - USD	0.04%	23 M€	-.--%	-
AMUNDI MSCI WORLD CLIMATE TRANSITION CTB UCITS ETF DR (C) - EUR	0.04%	786 M€	-.--%
LYXOR MSCI WORLD CLIMATE CHANGE (DR) UCITS ETF - ACC - USD	0.04%	206 M€	-.--%
AMUNDI INDEX MSCI WORLD UCITS ETF DR (D) - EUR	0.03%	607 M€	+0.05%	-
AMUNDI INDEX MSCI WORLD UCITS ETF - EUR	0.03%	1,166 M€	+0.26%	-
VANGUARD LIFESTRATEGY 80% EQUITY UCITS ETF - DISTRIBUTING - EUR	0.03%	36 M€	+9.83%	-
VANGUARD LIFESTRATEGY 80% EQUITY UCITS ETF ACC - EUR	0.03%	414 M€	+10.01%	-
UNLIMITED HFND MULTI-STRATEGY RETURN TRACKER ETF - USD	0.02%	32 M€	+4.30%	-
VANGUARD LIFESTRATEGY 60% EQUITY UCITS ETF - DISTRIBUTING - EUR	0.02%	40 M€	+6.57%	-
VANGUARD LIFESTRATEGY 60% EQUITY UCITS ETF - ACC - EUR	0.02%	324 M€	+6.59%	-
VANGUARD LIFESTRATEGY 40% EQUITY UCITS ETF - DISTRIBUTING - EUR	0.01%	17 M€	+3.59%	-
VANGUARD LIFESTRATEGY 40% EQUITY UCITS ETF ACC - EUR	0.01%	104 M€	+4.15%	-
VANGUARD LIFESTRATEGY 20% EQUITY UCITS ETF - DISTRIBUTING - EUR	0.01%	8 M€	+1.08%	-
VANGUARD LIFESTRATEGY 20% EQUITY UCITS ETF ACC - EUR	0.01%	55 M€	+1.07%	-
ADAPTIVE GROWTH OPPORTUNITIES ETF - USD	0.01%	248 M€	+11.05%	-

Chugai Pharmaceutical Co. Ltd specializes in the research, development, manufacturing and marketing of drugs especially for cancers (40.8% of net sales), bones and joints diseases treatment (18.4%), and kidney diseases (5.9%). Net sales are distributed geographically as follows: Japan (74,3%), Switzerland (22,8%) and other (2,9%).

Sector

Pharmaceuticals

Calendar

2024-06-26 - Détachement de for dividende intermédiaire

Related indices

Nikkei 225

More about the company

Income Statement Evolution

More financial data

Ratings for Chugai Pharmaceutical Co., Ltd

Trading Rating

Investor Rating

ESG Refinitiv

A-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

4,757 JPY

Average target price

5,932 JPY

Spread / Average Target

+24.70%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
CHUGAI PHARMACEUTICAL CO., LTD	-9.62%	49.99B
ELI LILLY AND COMPANY	+45.82%	765B
JOHNSON & JOHNSON	-6.16%	354B
MERCK & CO., INC.	+19.86%	331B
ABBVIE INC.	+9.32%	299B
ASTRAZENECA PLC	+18.45%	248B
ROCHE HOLDING AG	-0.78%	219B
NOVARTIS AG	+11.88%	216B
AMGEN INC.	+5.90%	164B
PFIZER, INC.	-0.73%	162B

Other Pharmaceuticals

Delayed Japan Exchange Other stock markets 00:55:46 2024-06-10 EDT			5-day change	1st Jan Change
4,828 ^JPY	+1.49%		+0.33%	-9.62%

05-23	Tech stocks lift Japan's Nikkei on boost from Nvidia's robust outlook	RE
05-14	Japan's Nikkei drifts sideways as more earnings, US CPI awaited	RE